Our group uses engineering, chemistry, and biology to gain a fundamental understanding of the nano-bio interface, focusing on both the materials properties and biological features needed for successful drug delivery. Specifically, we develop and utilize toolsets that enable high throughput and pooled screening of nanocarriers. We also leverage large omics datasets to gain insight into biological interactions with nanomaterials. Taken together, our research allows us to take a holistic approach to understanding and advancing nanomedicine.
We are dedicated to creating a safe, inclusive, and collaborative space to study the fundamentals of drug delivery together.